← FDA DRUG APPROVALS

FDA ANDA · ANDA075057

CLOBETASOL PROPIONATE

Sponsor: AUROBINDO PHARMA USA

APPLICATION
ANDA075057
TYPE
ANDA
ORIGINAL APPROVAL
1998-08-12
LATEST ACTION
2000-12-27
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

CLOBETASOL PROPIONATEPrescription
CLOBETASOL PROPIONATE 0.05% · OINTMENT · TOPICAL

Approval history

2000-12-27Manufacturing (CMC) · Supplement 1AP
1998-08-12OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →